Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Return on Equity (2020 - 2022)

Atea Pharmaceuticals has reported Return on Equity over the past 3 years, most recently at 0.05% for Q3 2022.

  • Quarterly results put Return on Equity at 0.05% for Q3 2022, up 1.0% from a year ago — trailing twelve months through Sep 2022 was 0.05% (up 1.0% YoY), and the annual figure for FY2021 was 0.19%, changed.
  • Return on Equity for Q3 2022 was 0.05% at Atea Pharmaceuticals, up from 0.02% in the prior quarter.
  • Over the last five years, Return on Equity for AVIR hit a ceiling of 0.19% in Q4 2021 and a floor of 0.05% in Q4 2020.
  • Median Return on Equity over the past 3 years was 0.05% (2021), compared with a mean of 0.05%.
  • Biggest five-year swings in Return on Equity: rose 23bps in 2021 and later decreased -4bps in 2022.
  • Atea Pharmaceuticals' Return on Equity stood at 0.05% in 2020, then skyrocketed by 504bps to 0.19% in 2021, then tumbled by -71bps to 0.05% in 2022.
  • The last three reported values for Return on Equity were 0.05% (Q3 2022), 0.02% (Q2 2022), and 0.07% (Q1 2022) per Business Quant data.